Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the field of biopharmaceuticals, featuring promising advancements throughout many medical and industrial programs. With its structural similarity to The natural way derived human serum albumin, OsrHSA delivers a safer, more trustworthy alternate for therapeutic use,